Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa

Diagn Microbiol Infect Dis. 2005 Feb;51(2):113-7. doi: 10.1016/j.diagmicrobio.2004.09.004.

Abstract

The application of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa might be of clinical relevance if they possess a significant postantibiotic effect (PAE). Twenty-two nosocomial isolates were exposed over time to ceftazidime, imipenem, or ciprofloxacin, and to their interaction with amikacin; all were applied at concentrations equal to their average serum level. After 24 h of exposure, live cells were washed and resuspended into fresh broth, and bacterial growth was monitored. PAE was found only for isolates subjected to the synergistic effect of the applied interactions. For these isolates, the mean PAEs (+/-SE) were 3.10 +/- 0.71 h for ceftazidime and amikacin, 4.38 +/- 0.83 h for imipenem and amikacin, and 3.33 +/- 2.83 h for ciprofloxacin and amikacin. The prolonged PAE documented after exposure to the interactions of the studied drugs strengthens the application of their combination for the management of infections by multidrug-resistant P. aeruginosa.

Publication types

  • Comparative Study

MeSH terms

  • Amikacin / pharmacology
  • Ceftazidime / pharmacology
  • Cross Infection / drug therapy
  • Cross Infection / microbiology
  • Drug Resistance, Multiple, Bacterial*
  • Drug Synergism
  • Drug Therapy, Combination / pharmacology*
  • Humans
  • Imipenem / pharmacology
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification*
  • Sensitivity and Specificity

Substances

  • Imipenem
  • Amikacin
  • Ceftazidime